Sept 30 (Reuters) – The U.S. Food and Drug Administration has approved Novartis' oral treatment for patients with type of chronic inflammatory skin disease, the company said on Tuesday. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Sahal Muhammed)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Oct 16 (Reuters) - Google's Waymo said on Friday it plans to bring its autonomous…
By Anhata Rooprai and Aditya Soni Oct 15 (Reuters) - CoreWeave's mounting debt is raising…
By Eduardo Baptista BEIJING, Oct 16 (Reuters) - China proposed export controls on 23 AI…
SHELL SAYS IT IS CONSIDERING A SALE OF ITS RETAIL FORECOURTS BUSINESS IN FRANCE (The…
New Delhi [India], October 16: India is in middle of one of the biggest urban…
By Paul Sandle and Yadarisa Shabong LONDON, Oct 16 (Reuters) - Britain's competition watchdog proposed…